Aroa Biosurgery Ltd (ARX)
20mins delayed
Movement
1 Year Return
Aroa Biosurgery Ltd Chart
| Share price | |
| Last | |
| Change | |
| Volume | |
| Turnover | |
| Market Cap | $436.61 million |
| Today's Movement | |
| Prev. Close | |
| Open | |
| Day Range | - |
| VWAP | |
| Historical Stats | |
| 52w Range | - |
| 4w Avg Volume | |
| 4w Avg Turnover | |
| (delayed) | |
ARX Statistics
11 August
383 / 2,229
ASX Size Rank
1yr Return
vs Sector (1yr)
-12.63%
vs ASX 200 (1yr)
+14.63%
$436.61 million
Market Cap
Share Issue
300.07 million
All Ords (%)
N/A
Short Sold
0.02%
Current Fundamentals
11 August
N/A
PE Ratio
EPS ($)
-
Earnings Yield
-
NTA ($)
-
N/A
Dividend Yield
DPS ($)
-
Gross Div. Yield
-
Gross DPS ($)
-
Company Overview
Aroa Biosurgery Limited (ARX) is a soft tissue regeneration company focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. It participates in the wound care and surgical reconstruction markets. Its products currently for sale in the key US market target chronic wounds and soft tissue reconstruction including, hernia, breast reconstruction and trauma/limb salvage/ tumour surgery.
Upcoming Calendar
Dividend History
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| No dividends paid in the last 5 years | ||||
See Upcoming Dividends for all ASX companies.
Announcements
| Date | Heading | Pages | File Size | Time |
|---|---|---|---|---|
Broker Consensus
The buy, hold and sell recommendations from Australian stockbroking firms are combined to form a "broker consensus". See the Consensus Data posts for more information.
ARX is not covered by a major broker,
or data from most recent compilation was omitted due
to not meeting QA guidelines.
Directors & Management
| Name | Title | Since | Bio |
|---|---|---|---|
| Mr John Flower Diddams | Non-Executive Director | Nov 2019 |
|
| Mr Philip John McCaw | Non-Executive Director | Mar 2008 |
|
| Mr James (Jim) Neil McLean | Non-Executive Chairman, Non-Executive Director | Aug 2011 |
|
| Mr Steven (Steve) Barnard Engle | Non-Executive Director | Apr 2015 |
|
| Mr John Richard Pinion II | Non-Executive Director | Feb 2015 |
|
| Mr Brian Roderick Ward | Chief Executive Officer, Managing Director | Sep 2007 |
|
| Ms Tracy Weimar | Joint Company Secretary | Jul 2020 | |
| Mr James Blair Agnew | Chief Financial Officer, Joint Company Secretary | - |
Director Transactions
ARX directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
There are no director transactions for code ARX in our database.
Shareholder Distribution
Shareholder Distribution data is unavailable.
Top 20 Shareholders
| Name | Shares | Capital |
|---|---|---|
| Brian Ward and Tracey Ward |
33,125,800 | 11.04% |
| Movac Fund 3 Lp | 25,841,850 | 8.61% |
| Phill Mccaw |
16,722,425 | 5.57% |
| Richard Abbott |
11,579,775 | 3.86% |
| Aspre Nz Seed Fund Ltd | 10,332,407 | 3.44% |
| Sparkbox Investment Ltd | 10,085,633 | 3.36% |
| National Nominees Limited | 9,835,163 | 3.28% |
| HSBC Custody Nominees (Australia) Limited | 9,227,800 | 3.08% |
| BNP Paribas Noms Pty Ltd |
8,450,700 | 2.82% |
| Firetrail Investment Pty Ltd |
6,374,625 | 2.12% |
| K One W One |
6,359,475 | 2.12% |
| Mark Ritcher |
6,016,350 | 2.00% |
| Mesynthes Nominee Ltd | 5,354,175 | 1.78% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 4,919,267 | 1.64% |
| Sharon Bryant |
4,815,198 | 1.60% |
| Washington H Soul Pattinson and Company Ltd | 4,583,325 | 1.53% |
| Hollister Inc | 4,268,840 | 1.42% |
| Nancy Yopp | 3,913,842 | 1.30% |
| K One W One Ltd | 3,881,342 | 1.29% |
| Movac Sidecar Fund Lp | 3,864,750 | 1.29% |
| All other shareholders | 36.85 % | |
The Top 20 Shareholders of ARX hold 63.15% of shares on issue.
ARX Share Price History
| Date | Close | Change | % Change | Open | High | Low | Volume | Turnover |
|---|---|---|---|---|---|---|---|---|
ARX Historical Data
Download up to 20 years of share price history.
| Year | Closing Price (30 June) | Last Trade |
|---|
Offical data as published by ASX. See more Data Downloads.
Company Details
Principal Activity: Designing and selling regenerative healing products.
Incorporated: --
2 Kingsford Smith Pl
Mangere Auckland New Zealand 2022
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.